Patents by Inventor Benjamin Lee Hughes

Benjamin Lee Hughes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7112341
    Abstract: Provided are stabilized follicle stimulating protein (FSP) dry powder compositions for aerosolized delivery to the deep lung, methods of preparing and administering such compositions, and methods for treating infertility involving administering the dry powders by pulmonary delivery to the deep lung.
    Type: Grant
    Filed: April 13, 2000
    Date of Patent: September 26, 2006
    Assignee: Nektar Therapeutics
    Inventors: Sudha Nagarajan, John S. Patton, David B. Bennett, Joanne Greene, Hi-Shi Chiang, Cheryl L. M. Stults, Geraldine Venthoye, Darrel LaVern Allen, Benjamin Lee Hughes, Mary Stiff-Torvik, Ronald Keith Wolff, William David Roeder
  • Publication number: 20040120897
    Abstract: The claimed invention relates to a method of administering glucagon-like peptide-1 molecules by inhalation, a method for treating diabetes by administering glucagon-like peptide-1 molecules by inhalation, and a method for treating hyperglycemia by administering glucagon-like peptide-1 molecules by inhalation.
    Type: Application
    Filed: December 10, 2003
    Publication date: June 24, 2004
    Inventors: Benjamin Lee Hughes, Ronald Keith Wolff
  • Patent number: 6720407
    Abstract: The claimed invention relates to a method of administering glucagon-like peptide-1 molecules by inhalation, a method for treating diabetes by administering glucagon-like peptide-1 molecules by inhalation, and a method for treating hyperglycemia by administering glucagon-like peptide-1 molecules by inhalation.
    Type: Grant
    Filed: August 26, 1999
    Date of Patent: April 13, 2004
    Assignee: Eli Lilly and Company
    Inventors: Benjamin Lee Hughes, Ronald Keith Wolff
  • Patent number: 6335316
    Abstract: The invention relates to a method of administering a fatty acid-acylated insulin or insulin analog by inhalation, a method for treating diabetes by administering a fatty acid-acylated insulin or insulin analog by inhalation, and a method for treating hyperglycemia by administering a fatty acid-acylated insulin or insulin analog by inhalation.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: January 1, 2002
    Assignee: Eli Lilly and Company
    Inventors: Benjamin Lee Hughes, Ronald Keith Wolff
  • Patent number: 6051551
    Abstract: The invention relates to a method of administering a fatty acid-acylated insulin or insulin analog by inhalation, a method for treating diabetes by administering a fatty acid-acylated insulin or insulin analog by inhalation, and a method for treating hyperglycemia by administering a fatty acid-acylated insulin or insulin analog by inhalation.
    Type: Grant
    Filed: October 29, 1998
    Date of Patent: April 18, 2000
    Assignee: Eli Lilly and Company
    Inventors: Benjamin Lee Hughes, Ronald Keith Wolff